How does clarithromycin work in the body?
Clarithromycin is a macrolide antibiotic. It works by binding to the bacterial 50S ribosomal subunit and blocking protein synthesis. More specifically, it interferes with the translocation step during translation, which prevents bacteria from building proteins needed for growth and replication.
Is clarithromycin bactericidal or bacteriostatic?
Clarithromycin is generally considered bacteriostatic at typical concentrations because it stops bacterial growth by halting protein synthesis rather than directly killing bacteria. However, clinical effect can still be bactericidal against some organisms and in certain conditions.
What bacteria targets does the mechanism affect?
Because its action depends on bacterial protein production, clarithromycin is most effective against bacteria that rely on active translation. That includes many common Gram-positive organisms and several respiratory pathogens, where ribosomal inhibition disrupts their ability to proliferate.
Does clarithromycin use the same mechanism as other macrolides?
Yes. Clarithromycin shares the core macrolide mechanism with other drugs in its class (like erythromycin and azithromycin): binding to the 50S ribosomal subunit to inhibit bacterial protein synthesis.
What resistance mechanisms can reduce clarithromycin effectiveness?
Common resistance routes can undermine macrolide binding or increase its efflux from bacterial cells. The most relevant ones include:
- Target modification (changes to ribosomal binding sites that lower drug affinity)
- Enzymatic drug inactivation
- Efflux pumps that reduce intracellular drug concentration
These resistance mechanisms can lead to higher failure rates even when the drug is otherwise prescribed appropriately.